I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Pranita D Tamma, M.D.
Director, Pediatric Antimicrobial Stewardship Program
Associate Professor of Pediatrics
Expertise: Pediatric Infectious Diseases
Research Interests: Diagnosing and treating multidrug-resistant infections; improving antibiotic use among children and adults
The Johns Hopkins Hospital (Main Entrance)
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map
Johns Hopkins Harriet Lane Clinic
200 N. Wolfe Street
Rubenstein Child Health Building, Suite 3149
Baltimore, MD 21287 map
Pranita Tamma, M.D., M.H.S. is an Associate Professor of Pediatrics, Division of Infectious Diseases and Director of the Pediatric Antimicrobial Stewardship Program at The Johns Hopkins University School of Medicine. As Director of Antimicrobial Stewardship, she assists clinicians with optimizing the selection of antibiotics, developing guidelines to promote the appropriate and judicious use of antibiotics, and monitoring patient outcomes after implementation of these practices. She is the past and present recipient of federal research funding from the National Institute of Health, Food and Drug Administration, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality. Her research focuses on clinical outcomes related to antibiotic administration strategies in both children and adults. She is particularly interested in improving diagnostics and therapeutic choices for infections caused by multidrug resistant gram-negative organisms.
Dr. Tamma was a member of the Society of Healthcare Epidemiology (SHEA) Antibiotic Stewardship Committee from 2014-2017 and is currently a member of The Pediatric Infectious Diseases Society Antimicrobial Stewardship Committee. Dr. Tamma serves a Voting Member of the Clinical Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Committee and is a member of the CDC Working Group on Improving Inpatient Antibiotic Prescribing. She is an editor of SHEA-sponsored textbook “Practical Implementation of Antibiotic Stewardship Program.”
- Director, Pediatric Antimicrobial Stewardship Program
- Associate Professor of Pediatrics
- MD, SUNY at Brooklyn College of Medicine (2004)
- Johns Hopkins University School of Medicine / Pediatrics (2007)
- Johns Hopkins University School of Medicine / Pediatric Infectious Diseases (2011)
- American Board of Pediatrics / Pediatric Infectious Diseases (2011)
Research & Publications
Selected PublicationsView all on Pubmed
Goodman K, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Masey C, & Tamma PD. A clinical decision tree to predict whether a bacteremic patient is infected with an ESBL-producing organism. Clin Infect Dis. 2016 Jun 28. pii: ciw425. [Epub ahead of print]
Suwantarat N, Logan LK, Carroll KC, Bonomo RA, Simner PJ, Rudin S, Milstone AM, Tekle T, Ross MT, Tamma PD. The prevalence and molecular epidemiology of multidrug-resistant Enterobacteriaceae colonization in a pediatric intensive care unit. Infect Control Hosp Epidemiol. 2016;37(5):535-43.
Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE. Carbapenem therapy is associated with improved survival compared to piperacillin-tazobactam in patients with ESBL bacteremia. Clin Infect Dis. 2015; 60:1319-25
Tamma PD, Goodman KE, Harris AD, Tekle T, Robert A, Taiwo A, & Simner PJ. Comparing the Outcomes of Patients with Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clinical Infectious Diseases 2017;64(3):257-264.
Tamma PD, Opene BNA, Gluck A, Chambers K, Carroll KC, & Simner PJ. A Comparison of Eleven Phenotypic Assays for the Accurate Detection of Carbapenemase-Producing Enterobacteriaceae. Journal of Clinical Microbiology; 2017; 64(3):257-264
Activities & Honors
- Society for Healthcare Epidemiology of America, 2009
- The Pediatric Infectious Diseases Society, 2008
- Infectious Diseases Society of America, 2008